(and dosage form):
Each 4 g contains
|| 0,613 g|
|| 1,716 g|
|Citric acid anhydrous
|| 0,702 g|
|| 0,858 g|
A 18.3 Medicines acting on genito-urinary system - Ion exchange preparations.
ADCO-SODASOL has gastric antacid as well as urinary alkalinising properties.
ADCO-SODASOL is a gastric antacid and urinary alkalinising agent. ADCO-SODASOL may be used to prevent crystalluria during treatment with sulphonamides.
ADCO-SODASOL should not be administered to patients with severe renal disease and metabolic disturbances with alkalosis, hypocalcaemia or hypochlorhydria.
ADCO-SODASOL should not be administered with urinary tract antiseptics which require an acid urine, such as methenamine mandelate and methenamine hippurate.
ADCO-SODASOL should be used with care in patients suffering from renal insufficiency.
Alkalinising agents do not eradicate bacteriuria although they may temporarily relieve lower urinary tract symptoms.
Concomitant use of ADCO-SODASOL with an antacid by patients with compromised renal function may result in the absorption of dangerously high amounts of aluminium.
Patients suffering from congestive cardiac failure and hypertension should not use ADCO-SODASOL except under the advice and supervision of a doctor.
DOSAGE AND DIRECTIONS FOR USE:
ADULTS: One to two medicine measuresful (4 to 8 g) in half a glass of water, 2 to 3 times daily, taken on an empty stomach and followed with additional water.
Drink after effervescence.
CHILDREN (6 -12 years): One medicine measureful (4 g) in half a glass of water, 2 to 3 times daily, taken on an empty stomach and followed with additional water.
Drink after effervescence.
SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Abdominal distention, flatulence, belching and nausea may occur if ADCO-SODASOL is taken before effervescence is complete.
Excessive administration of ADCO-SODASOL may lead to metabolic alkalosis especially in patients with impaired renal function. Symptoms may include shortness of breath, muscle weakness and mental disturbances such as restlessness, convulsions and coma.
Muscle hypertonicity, twitching and tetany may develop especially in hypocalcaemic patients.
Excessive doses may lead to sodium overloading and hyperosmolality with resulting oedema and possible effect on the cerebral, pulmonary or peripheral circulations.
Stomach cramps and flatulence may occur.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Refer to side-effects and special precautions.
Treatment is symptomatic and supportive and consists mainly of correction of fluid and electrolyte balance. Consult a doctor in known cases of overdosage.
White to straw-coloured granules with a lemon odour and a sweet/sour slightly lemon taste.
After reconstitution with water, a clear colourless to straw-coloured solution with a slight lemon odour is obtained.
60 g, 100 g or 120 g of effervescent granules packed in a clear glass bottle with screw cap, and dosage measure.
Store in a cool (below 25°C), dry place in well-closed containers.
KEEP OUT OF REACH OF CHILDREN.
NAME AND BUSINESS ADDRESS OF APPLICANT:
ADCOCK INGRAM LIMITED
Adcock Ingram Park
17 Harrison Avenue
Bryanston Ext. 77
Private Bag X69, Bryanston, 2021, RSA.
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
New addition to this site: April 2004
Source: Pharmaceutical Industry
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
Information presented by Malahyde Information Systems © Copyright 1996-2004